Efficacy Study of Activated Prothrombin Complex for Prevention of Bleeds in Hemophilia A With Inhibitors

NCT00221195 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Hemophilia A With Inhibitors

Interventions

DRUG: activated prothrombin complex concentrate (FEIBA)

Sponsor

Tulane University School of Medicine